An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Trial Profile

An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2008

At a glance

  • Drugs Bortezomib (Primary) ; Omeprazole
  • Indications Non-Hodgkin's lymphoma; Solid tumours
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Millennium
  • Most Recent Events

    • 04 Jun 2008 Status changed from in progress to completed.
    • 12 Jul 2007 Status changed from recruiting to in progress.
    • 31 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top